Related Experiment Video
Updated: Jul 13, 2026
Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
Impact of bariatric surgery on type 2 diabetes
1Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL, USA. lmeneghi@med.miami.edu
Abstract:
The management and prevention of diabetes through lifestyle modifications and weight loss should be the mainstay of therapy in appropriate candidates. Although the results from the Diabetes Prevention Trial and the Finnish Prevention Study support this approach, over 95% of patients not participating in a prevention research study are unable to achieve and maintain any significant weight loss over time. Bariatric surgery for weight loss is an emerging option for more sustainable weight loss in the severely obese subject, especially when obesity is complicated by diabetes or other co-morbidities. The two most common types of procedures currently used in the United States are adjustable gastric bands and Roux-en-Y gastric bypass. These procedures can be performed laparoscopically, further reducing the perioperative morbidity and mortality associated with the surgery. While the gastric bypass procedure usually results is greater sustained weight loss (40-50%) than adjustable gastric banding (20-30%), it also carries greater morbidity and nutritional/metabolic issues, such as deficiencies in iron, B12, calcium, and vitamin D. Following bariatric surgery most subjects experience improvements in diabetes control, hypertension, dyslipidemia, and other obesity-related conditions. In patients with impaired glucose tolerance most studies report 99-100% prevention of progression to diabetes, while in subjects with diabetes prior to surgery, resolution of the disease is reported in 64-93% of the cases. While improvements in insulin resistance and beta-cell function are related to surgically induced weight loss, the rapid post-operative improvement in glycemia is possibly due to a combination of decreased nutrient intake and changes in gut hormones as a result of the bypassed intestine. Post-prandial hyperinsulinemic hypoglycemia associated with nesidioblastosis has been described in a series of patients following gastric bypass surgery, and may be related to the described changes in GLP-1 and other gut hormones.
Insights
Bariatric surgery offers sustainable weight loss for severe obesity, improving diabetes and related conditions. While effective, gastric bypass has higher risks than gastric banding, impacting nutrient levels.
Area of Science:
- Metabolic Surgery
- Obesity Management
- Diabetes Mellitus Treatment
Background:
- Lifestyle modifications are primary for diabetes management but often fail for sustained weight loss.
- Severe obesity complicates diabetes and necessitates advanced interventions.
- Bariatric surgery presents a viable option for significant, long-term weight reduction.
Purpose of the Study:
- Evaluate bariatric surgery as a sustainable weight loss solution for obese individuals with diabetes.
- Compare the efficacy and risks of adjustable gastric bands and Roux-en-Y gastric bypass.
- Assess the impact of bariatric surgery on diabetes control and related comorbidities.
Main Methods:
- Review of adjustable gastric banding and Roux-en-Y gastric bypass procedures.
- Analysis of weight loss outcomes (20-50%) and associated morbidities.
- Examination of effects on diabetes, hypertension, and dyslipidemia.
Main Results:
- Gastric bypass yields greater weight loss (40-50%) than gastric banding (20-30%) but with increased risks.
- Significant improvements observed in diabetes control, hypertension, and dyslipidemia post-surgery.
- Diabetes prevention in impaired glucose tolerance (99-100%) and resolution in existing diabetes (64-93%) reported.
Conclusions:
- Bariatric surgery is effective for sustainable weight loss and improving obesity-related comorbidities, particularly type 2 diabetes.
- Procedure selection requires balancing weight loss efficacy with potential nutritional and metabolic complications.
- Rapid glycemic improvements may involve altered gut hormone signaling and reduced nutrient intake.
Related Concept Videos
01:36Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
01:22Diabetes Mellitus: Type 2 and Gestational
01:24Type II Diabetes II: Pathophysiology
01:26Type II Diabetes I: Introduction
01:26Type I Diabetes II: Pathophysiology
01:20Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...